313 related articles for article (PubMed ID: 22746536)
1. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.
Kaidery NA; Banerjee R; Yang L; Smirnova NA; Hushpulian DM; Liby KT; Williams CR; Yamamoto M; Kensler TW; Ratan RR; Sporn MB; Beal MF; Gazaryan IG; Thomas B
Antioxid Redox Signal; 2013 Jan; 18(2):139-57. PubMed ID: 22746536
[TBL] [Abstract][Full Text] [Related]
2. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
3. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.
Innamorato NG; Jazwa A; Rojo AI; García C; Fernández-Ruiz J; Grochot-Przeczek A; Stachurska A; Jozkowicz A; Dulak J; Cuadrado A
PLoS One; 2010 Jul; 5(7):e11838. PubMed ID: 20676377
[TBL] [Abstract][Full Text] [Related]
4. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
[TBL] [Abstract][Full Text] [Related]
5. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.
Chen PC; Vargas MR; Pani AK; Smeyne RJ; Johnson DA; Kan YW; Johnson JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2933-8. PubMed ID: 19196989
[TBL] [Abstract][Full Text] [Related]
6. Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP
Guo X; Han C; Ma K; Xia Y; Wan F; Yin S; Kou L; Sun Y; Wu J; Hu J; Huang J; Xiong N; Wang T
Front Neurol; 2019; 10():271. PubMed ID: 30949126
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.
Lv E; Deng J; Yu Y; Wang Y; Gong X; Jia J; Wang X
Free Radic Res; 2015; 49(11):1296-307. PubMed ID: 26118717
[TBL] [Abstract][Full Text] [Related]
9. In vivo modulation of the Parkinsonian phenotype by Nrf2.
Burton NC; Kensler TW; Guilarte TR
Neurotoxicology; 2006 Dec; 27(6):1094-100. PubMed ID: 16959318
[TBL] [Abstract][Full Text] [Related]
10. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
Sampath C; Kalpana R; Ansah T; Charlton C; Hale A; Channon KM; Srinivasan S; Gangula PR
Dig Dis Sci; 2019 Dec; 64(12):3502-3517. PubMed ID: 31187328
[TBL] [Abstract][Full Text] [Related]
11. Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2.
Wang L; Yang H; Wang Q; Zhang Q; Wang Z; Zhang Q; Wu S; Li H
Toxicol Lett; 2018 Jul; 291():11-28. PubMed ID: 29627306
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
13. An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo.
Liang LP; Huang J; Fulton R; Day BJ; Patel M
J Neurosci; 2007 Apr; 27(16):4326-33. PubMed ID: 17442816
[TBL] [Abstract][Full Text] [Related]
14. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
[TBL] [Abstract][Full Text] [Related]
16. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
17. Puerarin suppresses MPP
Li X; Zhang J; Zhang X; Dong M
Food Chem Toxicol; 2020 Oct; 144():111644. PubMed ID: 32763437
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
[TBL] [Abstract][Full Text] [Related]
19. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of Tongtian oral liquid, a Traditional Chinese Medicine in the Parkinson's disease-induced zebrafish model.
Dongjie S; Rajendran RS; Xia Q; She G; Tu P; Zhang Y; Liu K
Biomed Pharmacother; 2022 Apr; 148():112706. PubMed ID: 35152046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
